SciELO - Scientific Electronic Library Online

 
vol.42 issue1Actualidad clínica-biológica de los linfomas T cutáneosTratamiento de anemia con eritropoyetina humana recombinante durante el embarazo en el trasplante renal author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Medicina

Print version ISSN 0034-7523On-line version ISSN 1561-302X

Abstract

ARECES DELGADO, Fernando  and  RODRIGUEZ ABREU, Delvys. Linfomas no hodgkinianos agresivos: ¿Después del CHOP sólo el CHOP?. Rev cubana med [online]. 2003, vol.42, n.1, pp.79-88. ISSN 0034-7523.

The aggressive NHLs (non-Hodgkin lymphomas) comprise the diffuse large B-cell NHLs (including the variant of primary mediastinal B-cell lymphoma), the anaplastic and null large T-cell lymphomas and the peripheral T-cell lymphomas. An international prognostic index was created taking into account age, serum levels of LDH, Performance Status and extranodal affection. The CHOP scheme is considered as the gold standard of those non-Hodgkin’s lymphoma of aggressive histology, both in limited and advanced disease. Patients with disseminated disease have curability indexes under 40 %, so multiple therapeutic strategies are being tested to improve these results. It has been found that it is possible to increase the dose of the main drugs in the CHOP schemes up to approximately the double of the standard with an accepted toxicity and better responses.

Keywords : LYMPHOMA, NON-HODGKIN [drug therapy]; DRUG THERAPY; ANTINEOPLASTIC AGENTS, COMBINED.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License